A variant upstream of IFNL3 (IL28B) creating a new interferon gene IFNL4 is associated with impaired clearance of hepatitis C virus
Ludmila Prokunina‐Olsson(National Cancer Institute), Thomas R. OʼBrien, David L. Thomas(Johns Hopkins University), Adam Mumy(National Institutes of Health), Wei Tang(Agency for Science, Technology and Research), Barbara Rehermann(United States Department of Health and Human Services), Heiyoung Park(National Institutes of Health), Faruk Sheikh(United States Food and Drug Administration), Patricia Porter‐Gill(National Institutes of Health), Dianna Hergott(University of Washington), Nathan Brand(University of California, San Francisco), McAnthony Tarway(National Institutes of Health), Harold Dickensheets(Center for Drug Evaluation and Research), Ruth M. Pfeiffer(National Institutes of Health), Charles D. Howell(University of Maryland, Baltimore), Sabrina Chen(Information Management Services), Brian R. Edlin(National Development and Research Institutes), Herbert L. Bonkovsky(Atrium Health Wake Forest Baptist), Timothy R. Morgan(VA Long Beach Healthcare System), Indu Kohaar(National Institutes of Health), Luyang Liu(Ocean University of China), Jacquie Astemborski(New York Academy of Medicine), Brian Muchmore(National Institutes of Health), Raymond P. Donnelly(Center for Biologics Evaluation and Research)
Cited by 922
Related Papers
Development of a simple noninvasive index to predict significant fibrosis in patients with HIV/HCV coinfection†‡
|Hepatology|2006|4.8k
Diagnosis, management, and treatment of hepatitis C: An update # † ‡
|Hepatology|2008|3k
A multisociety Delphi consensus statement on new fatty liver disease nomenclature
|Hepatology|2023|2.9k
A multisociety Delphi consensus statement on new fatty liver disease nomenclature
|Journal of Hepatology|2023|2.7k